港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

高瓴概念

548.862

-8.643-1.55%

涨家数：22

跌家数：29

平家数：4

市盈率：- -

高：559.914

开：557.505

低：546.355

收：557.505

数据加载中...

南方锰业盘中异动股价大跌5.80%

《分析》中国头部电商置监管风险于不顾，继续大打即时零售价格战

瑞银：政策利好汽车经销商盈利预期需求仍存不确定性

智通财经网

ETF午评 | 生物医药板块全面上涨，港股医疗ETF涨2%

港股异动 | 中国抗体-B涨超19%，配股筹资3.69亿港元用于临床试验

港股异动 | 中国抗体-B(03681.HK)再涨超20% 公司配股筹资净筹3.69亿港元拟用于SM03临床试验等项目

归创通桥再涨近6% 预计中期纯利同比增长66.9% 公司拥抱集采并积极布局海外

方达控股盘中异动大幅拉升5.52%

大行评级｜瑞银：物业管理行业首选绿城服务预计中期盈利增幅将达20%

心通医疗-B盘中异动早盘股价大涨5.51%

港股异动 | 医疗器械股早盘走高国家药品集采明确反内卷机构看好行业拐点机会

药明巨诺-B盘中异动大幅拉升5.10%报4.120港元

《股市简讯》中国生物科技公司云顶新耀大跌7.5%，拟折让约一成配售新股

港股异动 | 三生制药(01530)跌超4% 与辉瑞许可协议生效折让17.09%发新股筹7.85亿港元

归创通桥盘中异动急速上涨5.15%报23.500港元

信达生物盘中异动急速拉升3.06%

CRO概念盘中拉升，博腾股份涨6.77%

新股首日 | 维立志博-B(09887.HK)首挂上市早盘高开近107% 核心产品LBL-024为处于注册临床试验阶段的4-1BB靶向候选药物

期现一体化助力浙江打造全球大宗商品资源配置枢纽中的“永安实践”

期货日报网

【券商聚焦】中信证券：集采政策优化，支持创新发展

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1583/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":548.8622,"timestamp":1753430886241,"preClose":557.50507,"halted":0,"volume":1338784034,"delay":0,"changeRate":-0.015503,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-8.642883,"latestTime":"07-25 16:00:00","open":557.50507,"high":559.9138,"low":546.3554,"amount":24858306293.5,"amplitude":0.02432,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753407000000,1753416000000],[1753419600000,1753430400000]],"pbRate":2.557207,"peRate":23.85406,"turnoverRate":0.009679,"increases":21,"decrements":31,"flats":1,"marketCap":3163113933696,"floatMarketCap":2433989616768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":559.9138,"amplitude":0.02432,"preClose":557.50507,"low":546.3554,"pbRate":"2.557207","latestPrice":548.8622,"volume":1338784034,"delay":0,"open":557.50507,"prevYearClose":446.93042,"prevWeekClose":544.363,"prevMonthClose":500.645,"prevQuarterClose":500.645,"fiveDayClose":544.363,"twentyDayClose":510.136,"sixtyDayClose":471.383,"secType":"PLATE","market":"HK","turnoverRate":0.009679,"peRate":23.85406,"marketCap":3163113933696,"floatMarketCap":2433989616768,"timestamp":1753430886241,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":22,"down":29,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554756929","title":"南方锰业盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554756929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554756929?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 13:11","pubTimestamp":1753420260,"startTime":"0","endTime":"0","summary":"2025年07月25日下午盘13时11分，南方锰业股票出现波动，股价急速下跌5.80%。截至发稿，该股报0.325港元/股，成交量335.8万股，换手率0.08%，振幅5.80%。资金方面，该股资金流入21.1765万港元，流出87.8915万港元。南方锰业股票所在的其它金属矿物行业中，整体涨幅为0.13%。其相关个股中，北方矿业、能源及能量环球、天齐锂业涨幅较大，振幅较大的相关个股有北方矿业、能源及能量环球、中国诚通发展集团，振幅分别为35.14%、11.00%、9.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072513110094b9c90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072513110094b9c90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01091","BK1190","BK1592"],"gpt_icon":0},{"id":"2554753403","title":"《分析》中国头部电商置监管风险于不顾，继续大打即时零售价格战","url":"https://stock-news.laohu8.com/highlight/detail?id=2554753403","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554753403?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 12:45","pubTimestamp":1753418718,"startTime":"0","endTime":"0","summary":"《分析》中国头部电商置监管风险于不顾，继续大打即时零售价格战路透上海/北京7月25日 - 中国最大几家电商平台之间的\"即时零售\"价格战还没有要停下来的迹象，对于官方的批评声竟然罕见地置之不顾，表明即时零售对于电商的未来而言，几乎到了事关生死的地步。即时零售和随之而来的价格战比比皆是，比如阿里巴巴发放60分钟送达的早餐闪购红包，美团的茶饮几乎成了\"零元购\"。阿里巴巴、京东和美团没有回应置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nL6T3TM054:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683595622.HKD","LU1328615791.USD","HK0000306701.USD","09618","LU0181495838.USD","JD","LU1023057109.AUD","LU0979878070.USD","IE00BF5LJ272.USD","LU0823413587.USD","LU0106252389.USD","LU1201861165.SGD","SG9999001226.SGD","LU0054450605.USD","LU0196878994.USD","LU0051755006.USD","HMTD.SI","LU0856984785.SGD","BK1583","89988","LU2097828805.USD","BK1588","SG9999001903.USD","LU0048597586.USD","LU0259732245.USD","LU0588545904.SGD","LU2476274720.SGD","METmain","LU1316542783.SGD","MPNGY","ALBmain","IE00BMPRXR70.SGD","LU1808992512.USD","LU1152091168.USD","LU0348784397.USD","03690","LU0823413660.USD","LU0918141705.HKD","LU0634319403.HKD","LU0828237940.HKD","LU0865486749.SGD","LU0149721374.USD","LU0264606111.USD","LU0315178854.USD","89618","LU1226287529.USD","BABA","LU0488056044.USD","HBBD.SI","09988"],"gpt_icon":1},{"id":"2554775168","title":"瑞银：政策利好汽车经销商盈利预期 需求仍存不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2554775168","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554775168?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 11:50","pubTimestamp":1753415437,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，中升控股及永达汽车近期股价反弹，相信是来自于反内卷政策，市场憧憬新车销售利润率改善;一些经销商结业的新闻令市场揣测行业未来迎来整合;以及投资者趁低吸纳较低估值股份。憧憬若政策有效遏制行业价格战，瑞银相信经销商盈利能力或显著改善。瑞银维持对中升控股及永达汽车的“沽售”评级，认为现阶段评估盈利潜在改善幅度仍言之过早。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","LU1102505762.USD","00881","LU0173614495.USD","LU0287142896.SGD","BK1520","BK1589","03669","BK1239","LU1166156734.SGD"],"gpt_icon":0},{"id":"2554758619","title":"ETF午评 | 生物医药板块全面上涨，港股医疗ETF涨2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554758619","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554758619?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 11:39","pubTimestamp":1753414744,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159619","07226","399001","BK4614","516020","515000","BK1574","399441","BK1583","BK4585","159688","HSCEI","BK4550","513330","516950","09997","516630","161715","515120","562600","159745","159945","512170","159828","FDN","BK1222","516750","588730","09996","159883","159982","399006","BK1100","159702","YANG","399300","BK4588","159715","HSTECH","159870","510410","000979.SH","161726"],"gpt_icon":0},{"id":"1107966336","title":"港股异动 | 中国抗体-B涨超19%，配股筹资3.69亿港元用于临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1107966336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107966336?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 11:34","pubTimestamp":1753414492,"startTime":"0","endTime":"0","summary":"7月25日，中国抗体-B盘中涨超19%，公司配股筹资净筹3.69亿港元，拟用于SM03临床试验等项目。消息面上，中国抗体公告，拟发行1.82亿股新股份，认购价为每股2.03港元。该决定乃经内部评估后作出，该评估确定需要补充早期疗效的证据以支持BLA的审批。公司对舒西利单抗获批准于中国上市仍具信心，已开始规划舒西利单抗用于治疗系统性红斑狼疮的新临床开发计划。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1321863.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","BK1141","03681","BK1161","BK1574","BK1576","BK4614"],"gpt_icon":0},{"id":"2554675834","title":"港股异动 | 中国抗体-B(03681.HK)再涨超20% 公司配股筹资净筹3.69亿港元 拟用于SM03临床试验等项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2554675834","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554675834?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 11:25","pubTimestamp":1753413958,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1141","BK1161","BK1574","03681","03347","BK1576"],"gpt_icon":0},{"id":"2554758805","title":"归创通桥再涨近6% 预计中期纯利同比增长66.9% 公司拥抱集采并积极布局海外","url":"https://stock-news.laohu8.com/highlight/detail?id=2554758805","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554758805?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 10:45","pubTimestamp":1753411511,"startTime":"0","endTime":"0","summary":"归创通桥再涨近6%，截至发稿，涨2.91%，报23港元，成交额909.88万港元。消息面上，归创通桥公布，预期截至今年6月底止六个月的收入将超过4.8亿元人民币，同比增长约31.1%，去年同期为3.66亿元人民币。集团预计今年首六个月的纯利将超过1.15亿元人民币，同比增长约66.9%。华创证券指出，归创通桥在神经介入、外周介入产品线布局全面，截止今年3月20日，公司共战略布局66款产品及候选产品，已在国内商业化产品共计47款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725110406a4625f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725110406a4625f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02190","BK1100","BK1587","BK1583","BK1574"],"gpt_icon":0},{"id":"2554656737","title":"方达控股盘中异动 大幅拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554656737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554656737?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 10:08","pubTimestamp":1753409314,"startTime":"0","endTime":"0","summary":"2025年07月25日早盘10时08分，方达控股股票出现波动，股价快速拉升5.52%。截至发稿，该股报1.720港元/股，成交量24.6万股，换手率0.01%，振幅5.52%。资金方面，该股资金流入7.978万港元，流出33.548万港元。方达控股股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，维立志博-B、中国抗体-B、北海康成-B涨幅较大，振幅较大的相关个股有维立志博-B、奥星生命科技、中国抗体-B，振幅分别为21.00%、17.78%、12.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725100834a6c0a006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725100834a6c0a006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1576","01521","BK1141"],"gpt_icon":0},{"id":"2554773274","title":"大行评级｜瑞银：物业管理行业首选绿城服务 预计中期盈利增幅将达20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773274","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554773274?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 10:06","pubTimestamp":1753409208,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1583","02869","LU0051755006.USD","BK1258","LU0456827905.SGD","09983","01209","06958","BK1542","LU0456846285.SGD","01971","BK1229"],"gpt_icon":0},{"id":"2554376047","title":"心通医疗-B盘中异动 早盘股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554376047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554376047?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 10:03","pubTimestamp":1753409030,"startTime":"0","endTime":"0","summary":"2025年07月25日早盘10时03分，心通医疗-B股票出现波动，股价大幅拉升5.51%。截至发稿，该股报1.340港元/股，成交量422.1万股，换手率0.17%，振幅7.09%。心通医疗-B股票所在的医疗设备及用品行业中，整体涨幅为0.28%。其相关个股中，永胜医疗、爱康医疗、威高股份涨幅较大，振幅较大的相关个股有永胜医疗、春立医疗、微创医疗，振幅分别为13.64%、12.86%、11.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725100351a4623f70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725100351a4623f70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","BK1583","02160"],"gpt_icon":0},{"id":"2554327147","title":"港股异动 | 医疗器械股早盘走高 国家药品集采明确反内卷 机构看好行业拐点机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2554327147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554327147?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 10:00","pubTimestamp":1753408859,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1617","01066","01612","BK0251","BK1574","159883","BK1222","01789","01858","BK1585","LU0173614495.USD","LU0287142896.SGD","BK1100","09997","00853","BK1589","688236","BK1583","09996"],"gpt_icon":0},{"id":"2554732755","title":"药明巨诺-B盘中异动 大幅拉升5.10%报4.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554732755?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:53","pubTimestamp":1753408423,"startTime":"0","endTime":"0","summary":"2025年07月25日早盘09时53分，药明巨诺-B股票出现波动，股价急速上涨5.10%。截至发稿，该股报4.120港元/股，成交量78.15万股，换手率0.19%，振幅6.89%。资金方面，该股资金流入146.762万港元，流出117.591万港元。药明巨诺-B股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，维立志博-B、中国抗体-B、药明生物涨幅较大，振幅较大的相关个股有维立志博-B、奥星生命科技、中国抗体-B，振幅分别为21.00%、17.78%、12.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725095344971d36a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725095344971d36a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2554732377","title":"《股市简讯》中国生物科技公司云顶新耀大跌7.5%，拟折让约一成配售新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732377","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554732377?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:51","pubTimestamp":1753408274,"startTime":"0","endTime":"0","summary":"《股市简讯》中国生物科技公司云顶新耀大跌7.5%，拟折让约一成配售新股* 中国生物科技公司--云顶新耀1952.HK周五早盘低开5.9%，随后跌幅扩大至7.5%。* 该公司稍早公告称，拟配售2,256.1万股新股，配售价69.7港元，较周四收市价折让约10.12%，筹15.7亿港元，拟用于管线产品的全球研发、商业化推进工作、公司营运及一般行政管理开支。* 云顶新耀今年迄今大涨48.5%，同期恒生指数.HSI大幅上扬27.1%。* 恒生香港上市生物科技指数.HSHKBIO盘中一度升1.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nL4S3TM03T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01952","BK1583","BK1161"],"gpt_icon":0},{"id":"2554173239","title":"港股异动 | 三生制药(01530)跌超4% 与辉瑞许可协议生效 折让17.09%发新股筹7.85亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554173239","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554173239?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:47","pubTimestamp":1753408074,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药(01530)跌超4%，截至发稿，跌4.44%，报29.05港元，成交额5.25亿港元。消息面上，三生制药公布，公司与辉瑞就PD-1/VEGF双特异性抗体(SSGJ-707)订立的许可协议之所有先决条件已达成，许可协议自7月24日起生效。同日，双方订立认购协议，向辉瑞发行3114.25万股，每股作价25.2055港元，较7月24日收报折让17.09%，总金额约7.85亿港元。完成后，辉瑞将持有公司股本1.28%。所得净额约80%用于丰富产品管线中的临床及临床前项目的全球研发布局，以及改善生产设施；余额拨作一般公司用途。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","LU0456855351.SGD","LU1066053197.SGD","LU1066051498.USD","LU0868494617.USD","IE00B19Z3B42.SGD","SG9999001176.USD","BK4585","IE0002270589.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU0289739699.SGD","SG9999002224.SGD","BK4533","BK4534","BK4599","LU0234572021.USD","01530","SG9999002232.USD","BK4568","BK4550","LU0058720904.USD","BK1583","BK4581","LU0170899867.USD","IE00BLSP4452.SGD","BK1161","LU0122379950.USD","PFE","LU1883839398.USD","LU0321505439.SGD","LU0306806265.USD","IE00BLSP4239.USD","SG9999001176.SGD","LU1057294990.SGD","IE00BBT3K403.USD","LU0306807586.USD","IE000M9KFDE8.USD","BK4592","LU1023059063.AUD","LU1894683348.USD","LU0225284248.USD","BK4588","LU0225771236.USD","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4007","LU0985481810.HKD","SG9999011175.SGD"],"gpt_icon":0},{"id":"2554737984","title":"归创通桥盘中异动 急速上涨5.15%报23.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554737984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554737984?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:47","pubTimestamp":1753408056,"startTime":"0","endTime":"0","summary":"2025年07月25日早盘09时47分，归创通桥股票出现异动，股价大幅上涨5.15%。截至发稿，该股报23.500港元/股，成交量11.7万股，换手率0.04%，振幅4.92%。归创通桥股票所在的医疗设备及用品行业中，整体涨幅为0.03%。该信息摘要如下：归创通桥宣布，公司将于2025年8月19日（星期二）举行董事会会议，藉以审议及批准公司及其附属公司截至2025年6月30日止六个月的中期业绩及其发布，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725094736a6c0945f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725094736a6c0945f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1100","BK1574","02190","BK1583"],"gpt_icon":0},{"id":"2554373761","title":"信达生物盘中异动 急速拉升3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554373761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554373761?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:45","pubTimestamp":1753407945,"startTime":"0","endTime":"0","summary":"2025年07月25日早盘09时45分，信达生物股票出现波动，股价快速上涨3.06%。截至发稿，该股报90.900港元/股，成交量299.779万股，换手率0.18%，振幅3.34%。信达生物股票所在的药品行业中，整体跌幅为0.39%。其相关个股中，康龙化成、德琪医药-B、中国生物制药涨幅较大，振幅较大的相关个股有康龙化成、德琪医药-B、凯莱英，振幅分别为13.25%、9.13%、5.09%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725094545a6c09381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725094545a6c09381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","LU1969619763.USD","BK1583","01801","BK1161","LU2328871848.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2554328827","title":"CRO概念盘中拉升，博腾股份涨6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554328827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554328827?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:41","pubTimestamp":1753407714,"startTime":"0","endTime":"0","summary":"07月25日，CRO概念盘中拉升，截至09点41分，CRO概念整体指数上涨1.08%，报565.830点。从个股上来看，该概念的成分股中，博腾股份涨6.77%，亚太药业涨幅超过5%。从资金上来看，截止发稿，CRO概念主力净流入为1.41亿，其中药明康德受到资金热捧，主力净流入5759.26万；拉长时间线来看，该板块近20日主力资金净流入-7.23亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509415494b96ba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509415494b96ba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","02359","LU2125910500.SGD","LU1046422090.SGD","LU0320764599.SGD","LU2045819591.USD","BK1583","LU0052750758.USD","LU2242644610.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2554773464","title":"新股首日 | 维立志博-B(09887.HK)首挂上市 早盘高开近107% 核心产品LBL-024为处于注册临床试验阶段的4-1BB靶向候选药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773464","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554773464?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:24","pubTimestamp":1753406693,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","BK1141","BK1583","09887","03347"],"gpt_icon":0},{"id":"2554734581","title":"期现一体化助力浙江打造全球大宗商品资源配置枢纽中的“永安实践”","url":"https://stock-news.laohu8.com/highlight/detail?id=2554734581","media":"期货日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554734581?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 09:02","pubTimestamp":1753405336,"startTime":"0","endTime":"0","summary":"作为浙江期货行业的龙头，凭借着在大宗商品领域的深厚积累和创新实践，永安期货正以期现一体化为核心引擎，为浙江大宗商品生态注入动力，助力浙江在全球贸易网中打造大宗商品资源配置的“东方枢纽”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.qhrb.com.cn/articles/337264","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"qhrb_live","symbols":["BK1583","161631","LU1119993845.HKD","159739","000979.SH","BK6523","399300","SG9999000343.SGD","LU2242646235.USD","STI.SI","09983","LU0831103253.SGD","159981","SG9999013460.SGD","BK6033","FSTAS.SI","159945","BK1542","161715","399355","LU0898667661.SGD","159982","LU1920063259.USD","SG9999016042.SGD","LU2401740654.USD","BK1258","SG9999006266.SGD","LU0326948709.USD","BK0276","159871","SG9999004360.SGD","165316","LU0205439572.USD","SG9999001846.SGD","SG9999013478.USD","600927","BK1229","LU2242652126.USD","FSTM.SI","SGXZ58947870.SGD","S68.SI","SG9999014492.USD","SGXZ27511609.SGD","ES3.SI","000819.SH","LU0877626530.USD","SG9999014484.SGD","159940"],"gpt_icon":0},{"id":"2554731264","title":"【券商聚焦】中信证券：集采政策优化，支持创新发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2554731264","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554731264?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 08:59","pubTimestamp":1753405187,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示，2025年以来政府多次提出优化药品集采、支持创新药等相关政策，同时商保创新药目录出台在即，医药政策环境向好。2025年国家基本医保目录和商业健康保险创新药品目录调整启动，本次国谈最大的变化便是增设了商保创新药目录并与基本目录形成“双目录”并行模式。商保创新药目录的定位有望成为高价值创新药的缓冲平台，同时支付端给予“三除外”支持，有望为创新药在国内打开商业化空间带来助力。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962856","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU1115378108.SGD","LU1997245177.USD","06160","BK1197","600030","BK1588","BK0012","LU2495084118.USD","02196","BK1516","BK1161","LU0417516571.SGD","02268","06030","02228","LU0307460666.USD","BK1500","BK1585","LU0348783233.USD","09688","LU1064131003.USD","LU0348784397.USD","LU1720050803.USD","LU0405327494.USD","01530","BK0196","LU0588546209.SGD","01789","BK0183","BK1617","LU1969619763.USD","LU0640798160.USD","LU1997244956.HKD","LU2328871848.SGD","BK1141","BK0276","BK1515","BK1521","03933","LU2289578879.USD","01099","LU1328615791.USD","09926","LU1997245094.SGD","LU2488822045.USD","SG9999004311.SGD","BK0028","LU1064130708.USD","02367"],"gpt_icon":0}],"pageSize":20,"totalPage":50,"pageCount":4,"totalSize":991,"code":"91000000","status":"200"}]}}